Outlines requirements for the donor eligibility and collection, processing, storage, and administration of any type of cellular therapy product.
Current edition: 10th edition
Effective date: July 1, 2021
Revision cycle: 24 months (July of odd numbered years)
The print and Portal versions of the 10th edition of Standards for Cellular Therapy Services, are available for purchase.
AABB sets standards for and accredits facilities that procure, process, store and/or distribute cellular therapy products. The Standards for Cellular Therapy Services outlines the standards used as a basis for accreditation in cellular therapies activities, including:
These facilities are responsible for procuring, processing and storing umbilical cord blood stem cells that can be used for transplantation.
These facilities are responsible for procuring, processing and storing hematopoietic progenitor cells that can be used for transplantation.
These facilities perform one or more of the manufacturing steps for somatic cell products, including procurement, processing, storing and/or distributing.
These facilities are responsible for the administration of the product and all related patient care activities.